WAG » Topics » WALGREEN CO.

This excerpt taken from the WAG DEFA14A filed Dec 24, 2009.
WALGREEN CO.
____________________________________________________________________________________
(Name of Registrant as Specified In Its Charter)

____________________________________________________________________________________
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[x]  No fee required.
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 
 
1)  Title of each class of securities to which transaction applies:
____________________________________________________________________________________
2)  Aggregate number of securities to which transaction applies:
____________________________________________________________________________________
3)  Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11
    (set forth the amount on which the filing fee is calculated and state how it was determined):
____________________________________________________________________________________
4)  Proposed maximum aggregate value of transaction:
____________________________________________________________________________________
5)  Total fee paid:
____________________________________________________________________________________
 
[_] Fee paid previously with preliminary materials:
 
 
[_] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which
 
 
      the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or
 
 
      schedule and the date of its filing.
 
1) Amount previously paid:
____________________________________________________________________________________
2) Form, Schedule or Registration Statement No.:
____________________________________________________________________________________
3) Filing Party:
____________________________________________________________________________________
4) Date Filed:
____________________________________________________________________________________





WALGREENS
There's a way
December 23, 2009

Dear Shareholder:

You recently received proxy materials in relation to the annual shareholder meeting of Walgreen Co., to be held on Wednesday, January 13th, 2010.  This letter is to remind you that your vote is very important to us and according to our latest records, your
This excerpt taken from the WAG 8-K filed Oct 8, 2009.
WALGREEN CO.
(Exact name of registrant as specified in its charter)

Illinois
 
1-604
 
36-1924025
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

200 Wilmot Road, Deerfield, Illinois
 
60015
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code:
This excerpt taken from the WAG 8-K filed Jul 11, 2008.
WALGREEN CO.
(Exact name of registrant as specified in its charter)
         
Illinois   1-604   36-1924025
         
(State or other
jurisdiction of
incorporation)
  (Commission File
Number)
  (IRS Employer
Identification
Number)
     
200 Wilmot Road, Deerfield, Illinois   60015
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (847) 914-2500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01   Other Events
On July 10, 2008, the registrant issued a press release announcing its revised plans for organic store growth over the following three fiscal years. A copy of the press release is included as Exhibit 99.1 to this current report and is incorporated herein by reference.
Item 9.01   Financial Statements and Exhibits
     
Exhibit Number   Description
Exhibit 99.1
  Press Release dated July 10, 2008

 


 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  WALGREEN CO.
 
 
Date: July 11, 2008  By:   /s/ Wade D. Miquelon    
    Senior Vice President and Chief Financial Officer   
    (Principal Financial Officer)   
 

 

This excerpt taken from the WAG 8-K filed Jun 23, 2008.
WALGREEN CO.
(Exact name of registrant as specified in its charter)
 
Illinois  
1-604
36-1924025
(State or other
jurisdiction of
incorporation)
(Commission File 
Number)
  (IRS Employer
Identification No.)
 
 
200 Wilmot Road, Deerfield, Illinois 
60015
(Address of principal executive offices)  
(Zip Code)
 
Registrant’s telephone number, including area code: (847) 914-2500
 
This excerpt taken from the WAG 8-K filed May 13, 2008.
WALGREEN CO.
(Exact name of registrant as specified in its charter)

Illinois

1-604

36-1924025

(State or other

jurisdiction of

incorporation)

 

(Commission File

Number)

 

(IRS Employer

Identification

Number)

200 Wilmot Road, Deerfield, Illinois

60015

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code: (847) 914-2500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




This excerpt taken from the WAG 8-K filed Apr 29, 2008.
WALGREEN CO.
(Exact name of registrant as specified in its charter)
         
Illinois   1-604   36-1924025
         
(State or other
jurisdiction of
incorporation)
  (Commission File
Number)
  (IRS Employer
Identification
Number)
     
200 Wilmot Road, Deerfield, Illinois   60015
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (847) 914-2500
Not Applicable
 
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01 Other Events.
     On March 17, 2008, Walgreen Co., an Illinois corporation (the “Company”) and Putter Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Acquisition Sub”), announced they had entered into an Agreement and Plan of Merger (the “Merger Agreement”) with I-trax, Inc., a Delaware corporation (“I-trax”). Pursuant to the Merger Agreement, Acquisition Sub commenced cash tender offers to purchase all of the issued and outstanding shares of common stock, par value $0.001 per share (the “Common Shares”), and Series A Convertible Preferred Stock, par value $0.001 per share (the “Preferred Shares” and together with the Common Shares, the “Shares”) of I-trax for $5.40 per Common Share (the “Common Offer”) and $54.00 plus a dividend amount per Preferred Share (the “Preferred Offer”), in each case in cash, without interest and less any required withholding taxes (the “Offer Price”) upon the terms and subject to the conditions set forth in the Offer to Purchase included in the tender offer statement on Schedule TO and in the related Letter of Transmittal (as amended or supplemented from time to time) filed by the Company and Acquisition Sub with the U.S. Securities and Exchange Commission on March 28, 2008 (the “Offers”).
     On April 25, 2008, the Company issued a press release announcing the results of the Offers which expired at 12:00 midnight, New York City time, at the end of Thursday, April 24, 2008. The press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
The following exhibit is filed as part of this report:
     
Exhibit   Description
 
   
99.1
  Press Release, dated April 25, 2008 by Walgreen Co.

 


 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  WALGREEN CO.
 
 
Date: April 29, 2008  By:   /s/ William M. Rudolphsen    
    Senior Vice President and Chief
Financial Officer
(Principal Financial Officer) 
 
 
EXHIBIT INDEX
     
Exhibit   Description
 
   
99.1
  Press Release, dated April 25, 2008 by Walgreen Co.

 

This excerpt taken from the WAG 8-K filed Mar 4, 2008.
WALGREEN CO.     
(Exact name of registrant as specified in its charter)


This excerpt taken from the WAG 8-K filed Aug 16, 2007.
Walgreen Co.
(Exact name of registrant as specified in its charter)

Illinois   1-604   36-1924025
(State or other jurisdiction of   (Commission File Number)   (IRS Employer Identification No.)
incorporation)        

     

This excerpt taken from the WAG 8-K filed Jul 3, 2007.

About Walgreen Co.

     Walgreen Co. is the nation’s largest drugstore chain with fiscal 2006 sales of $47.4 billion. As of May 31, the company operated 5,751 stores in 48 states and Puerto Rico, including 77 Happy Harry’s stores in Delaware and surrounding states. Walgreens is expanding its patient-first health care services beyond traditional pharmacy through Walgreens Health Services, its managed care division, and Take Care Health Systems, a wholly-owned subsidiary that manages convenient care clinics inside drugstores. Walgreens Health Services assists pharmacy patients and prescription drug and medical plans through Walgreens Health Initiatives, Inc. (a pharmacy benefits manager), Walgreens Mail Service Inc., Walgreens Home Care Inc., and Walgreens Specialty Pharmacy.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki